Ricardo D. Parrondo, M.D.

Ricardo D. Parrondo, M.D., is a hematologist-oncologist, with a specialty interest in plasma cell dyscrasias and chronic lymphocytic leukemia. His clinical and research focus includes:

• Expertise in management of plasma cell dyscrasias such as multiple myeloma, MGUS, monoclonal gammopathies of clinical significance, Waldenstrom macroglobulinemia, AL amyloidosis, and POEMS syndrome
• Autologous hematopoietic cell transplantation for plasma cell dyscrasias
• Expertise in management of relapsed/refractory plasma cell dyscrasias
• Development of early and late-phase clinical trials for plasma cell dyscrasias
• Expertise in management of newly diagnosed and relapsed/refractory chronic lymphocytic leukemia
• Expertise in use of novel immunotherapeutic strategies for plasma cell dyscrasias and chronic lymphocytic leukemia such as CAR-T cell therapies and bispecific antibodies.

In addition to his clinical and research activities, Dr. Parrondo is active in education, providing mentorship to residents and fellows interested in hematologic malignancies. He publishes in high impact scientific journals and is at the helm of therapeutic discoveries for patients with plasma cell dyscrasias.